Olanzapine + Melatonin for Schizophrenia

"Olanzapine and melatonin have been clinically demonstrated to ameliorate acute coryza, mental depressiond melatonin have been clinically demonstrated to ameliorate acute coryza, mental depression, and post traumatic stress disorder (PTSD)."

"The requirements to join this trial are a diagnosis of schizophrenia and an age between 18-65. At present, roughly 20 participants must be recruited."

"The trial, which was initially announced on July 1st 2007 and last modified on October 6th 2022, is no longer seeking participants. For those searching for alternative trials, 2513 studies concerning schizophrenia are currently open to recruitment and 42 medical investigations involving olanzapine in combination with melatonin require patients."

"This clinical trial is only for those aged between 18 and 65. Patients under 18 have access to 592 trials, while 1597 studies are available to persons over the age of 65."

"Currently, there are 42 ongoing clinical trials involving olanzapine and melatonin with 8 at the later Phase 3. Of these experiments, a few take place in Toronto but 730 other medical centres across the world have active studies concerning this combination of medications."

"To date, 42 active clinical trails regarding olanzapine and melatonin have been conducted across 407 cities in 13 nations. The inaugural experiment was commissioned by Eli Lilly & Company in 2007 and featured 20 patients who successfully completed the necessary trials for drug approval. Since then, 335 additional experiments have been carried out."

"Unfortunately, the trial is not accepting enrolments at present. It was first posted on July 1st 2007 and most recently edited October 6th 2022. Alternatively, there are 2513 trials recruiting people with schizophrenia and 42 studies involving olanzapine and melatonin currently enrolling participants."